Panacos Pharmaceuticals, Inc.
Panacos Pharmaceuticals, Inc. (PANC) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
panc · pe ratio · data through Dec 31, 2007
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Panacos Pharmaceuticals, Inc. (PANC) measures how much investors pay for each dollar of the company's trailing earnings. PANC's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$0.70.
Source: FMP · /ratios-ttm · /analyst-estimates · 2007-12-31
PE Ratio History
1997 – 2007 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Biotechnology · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Panacos Pharmaceuticals, Inc.You PANC | $0M | N/A | — | -$0.70 |
 Arno Therapeutics, Inc. ARNI | $0M | N/A | — | -$0.57 |
 Better Therapeutics, Inc. BTTX | $0M | N/A | — | -$1.69 |
 Baudax Bio, Inc. BXRXQ | $0M | N/A | — | -$177.30 |
 Calithera Biosciences, Inc. CALA | $0M | N/A | — | -$3.78 |
 Innovation1 Biotech Inc. IVBT | $0M | N/A | — | -$0.30 |
 Inyx, Inc. IYXI | $0M | N/A | — | -$0.78 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2007-12-31Latest FY2007 | — | $-0.70 | — | |
2006-12-31 FY2006 | — | $-0.75 | — | |
2005-12-31 FY2005 | — | $-1.72 | — | |
2004-12-31 FY2004 | — | $-12.51 | — | |
2003-12-31 FY2003 | — | $-2.74 | — | |
2002-12-31 FY2002 | — | $-8.81 | — | |
2001-12-31 FY2001 | — | $-10.49 | — | |
2000-12-31 FY2000 | — | $-7.54 | — | |
1999-12-31 FY1999 | — | $-27.85 | — | |
1998-12-31 FY1998 | — | $-6.12 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Panacos Pharmaceuticals, Inc. (PANC) measures how much investors pay for each dollar of the company's trailing earnings. PANC's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$0.70.
Frequently asked questions
PANC pe ratio · 6 questionsPANC's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.00 and TTM EPS of -$0.70. Data sourced from Financial Modeling Prep via PANC's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Panacos Pharmaceuticals, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09